# üéØ COMPLETE INTEGRATION PLAN - ALL STARXDATA FILES

**Date:** November 6, 2025  
**Status:** CRITICAL - 16 FILES NOT YET INTEGRATED  
**Goal:** Integrate ALL data before PROMPT 5

---

## üìä CURRENT STATUS

**Total Files:** 30  
**‚úÖ Integrated:** 10 files (33%)  
**‚ùå Not Integrated:** 16 files (53%)  
**‚ö™ Not Needed:** 4 files (13%)

---

## üö® CRITICAL MISSING DATA

### Priority 1: COMPOUND TARGET IC50s (CRITICAL)

**File:** `UMF-814L target and IC50.csv`  
**Status:** ‚ùå NOT INTEGRATED  
**Content:**
```
Target:    MYLK4    STK17A    TBK1    CLK4
IC50:      2 nM     18 nM     135 nM  124 nM
```

**Why Critical:**
- Shows ACTUAL target potency for 814L compound
- Complements the 160-cell-line IC50 data
- Direct validation of target engagement
- Only 4 values but extremely important

**Integration Plan:**
1. Parse IC50 values for all 4 targets
2. Add to compound characterization
3. Include in report as target validation
4. Compare with cell-based IC50s

**Time:** 15 minutes

---

### Priority 2: CRISPR SCREEN DATA (HIGH VALUE)

**Files (3):**
- `UMF-814A-5_uM[46].csv` (934 KB) - Gene hits for 814A
- `UMF-815H-1_5_uMxxx_SF-R20xxx_S25_R1_001.csv` (915 KB) - Gene hits for 815H #1
- `UMF-815H-2_uMxxx_S19_SF-R20xxx_S25_R1_001.csv` (915 KB) - Gene hits for 815H #2

**Status:** ‚ùå NOT INTEGRATED  
**Content:** CRISPR screen results showing synthetic lethal genes

**Why High Value:**
- Identifies genes that are synthetic lethal with compounds
- Reveals mechanism of action
- Can identify combination therapy targets
- Validates pathway dependencies

**Integration Plan:**
1. Parse all 3 CRISPR screen files
2. Identify top synthetic lethal genes (p < 0.05, |score| > 2)
3. Cross-reference with our target genes (STK17A, MYLK4, TBK1, CLK4)
4. Add to pathway analysis
5. Include in combination therapy recommendations

**Time:** 2 hours

---

### Priority 3: AML DEG DATA (CRITICAL FOR AML VALIDATION)

**Files (6):**
- `STK17A_RNAseq_K562_DMSO_vs_814A_significant_genes.csv` (6.05 MB)
- `STK17A_RNAseq_K562_Parental_vs_STK17A_KD_significant_genes.csv` (6.35 MB)
- `STK17A_RNAseq_K562_Parental_vs_STK17B_KD_significant_genes.csv` (6.31 MB)
- `STK17A_RNAseq_K666N_DMSO_vs_814A_significant_genes.csv` (6.09 MB)
- `STK17A_RNAseq_K666N_Parental_vs_STK17A_KD_significant_genes.csv` (6.44 MB)
- `STK17A_RNAseq_K666N_Parental_vs_STK17B_KD_significant_genes.csv` (6.33 MB)

**Status:** ‚ö†Ô∏è PARSE FAILED (previously attempted but failed)  
**Content:** Differential expression for AML (K562 cell line variants)

**Why Critical:**
- AML currently has NO transcriptomic validation
- Would add DEG evidence for AML (currently exp val score = 0.062)
- Dr. Taylor's primary clinical interest
- Complements IC50 data

**Problem:** Previous parsing attempts failed - likely due to:
- Large file size (6 MB each)
- Unusual format or encoding
- Memory issues

**Integration Plan:**
1. Investigate file structure (sample first 100 rows)
2. Identify parsing issue (encoding, delimiter, format)
3. Fix parsing code
4. Extract significant genes (adjusted p < 0.05, |log2FC| > 1)
5. Count DEGs per condition
6. Update experimental validation score for AML
7. Recalculate final rankings

**Time:** 3-4 hours (debugging + integration)

---

### Priority 4: DOCKING DATA (STRUCTURAL VALIDATION)

**Files (6):**
- `7QUE_-_prepared_-_chainA.pdb` (485 KB) - Protein structure
- `814A.pdb` (6.7 KB) - Ligand structure
- `814H.pdb` (6.7 KB) - Ligand structure  
- `815K.pdb` (7.9 KB) - Ligand structure
- `815H_Modellingnochanges_.pse` (1.22 MB) - PyMOL session
- `STK17B_modelling_StroomAi.pse` (1.51 MB) - PyMOL session

**Status:** ‚ùå NOT INTEGRATED  
**Content:** Protein-ligand docking models

**Why Valuable:**
- Provides structural validation of binding
- Can extract binding energies
- Confirms target engagement
- Complements biochemical IC50 data

**Challenge:** 
- PDB files need parsing (can extract REMARK lines with energies)
- PSE files are binary (need PyMOL or alternative parser)

**Integration Plan:**

**Option A: Extract from PDB files (2 hours)**
1. Parse PDB REMARK lines for binding scores
2. Extract AutoDock or Vina scores if present
3. Create binding_energy summary
4. Add to compound characterization

**Option B: Manual extraction from PSE (30 min)**
1. Open in PyMOL (if available)
2. Extract binding energies manually
3. Create CSV with: compound, target, binding_energy, RMSD
4. Integrate into scoring

**Option C: Skip quantitative, use qualitative (5 min)**
1. Document that docking was performed
2. Note which compounds were modeled
3. Reference in report as supporting evidence
4. No quantitative integration

**Recommendation:** Try Option A, fallback to Option C if time-constrained

**Time:** 30 min - 2 hours

---

## ‚ö™ OPTIONAL DATA (NOT CRITICAL)

### QC/Metadata Files (4):

**Files:**
- `% viability-Table 1.csv` (87 KB) - Cell viability data
- `cell culture media-Table 1.csv` (11 KB) - Culture conditions
- `raw data (luminescence)-Table 1.csv` (109 KB) - Raw assay data
- `COMPOUND_SMILES.md` (3 KB) - Chemical structures

**Status:** ‚ö™ NOT USED  
**Why Not Critical:**
- Viability: IC50 already calculated from this data
- Media: Metadata only, not analytical
- Raw luminescence: IC50 is processed version
- SMILES: Reference only, not needed for analysis

**Decision:** SKIP for now, use only if specific questions arise

---

## üìã EXECUTION PLAN

### Phase 1: Quick Wins (30 minutes)

**Task 1.1: Integrate 814L IC50 Data (15 min)**
- Parse the 4 target IC50 values
- Add to compound summary
- Document in report

**Task 1.2: Document SMILES (if needed) (15 min)**
- Extract chemical structures
- Add to compound characterization

---

### Phase 2: High-Value Data (3 hours)

**Task 2.1: Integrate CRISPR Screen Data (2 hours)**
- Parse 3 CRISPR files (814A, 815H x2)
- Identify top synthetic lethal genes
- Cross-reference with targets
- Add to pathway/combination analysis

**Task 2.2: Attempt Docking Integration (1 hour)**
- Try PDB parsing for binding energies
- If successful, integrate
- If not, document qualitatively

---

### Phase 3: Critical AML Data (4 hours)

**Task 3.1: Debug AML DEG Parsing (2 hours)**
- Investigate file structure
- Fix parsing issues
- Validate data quality

**Task 3.2: Integrate AML DEGs (2 hours)**
- Count significant genes per condition
- Add to experimental validation
- Recalculate AML ranking
- Update all summaries

---

## üéØ EXPECTED OUTCOMES

### After All Integration:

**AML (Acute Myeloid Leukemia):**
- **Current:** 1/6 evidence (IC50 only), exp val = 0.062, rank #7
- **After:** 2-3/6 evidence (IC50 + DEG + maybe CRISPR), exp val = 0.3-0.5?, rank ~#5?
- **Impact:** Much stronger case for AML as Priority #2

**Glioblastoma:**
- **Current:** 6/6 evidence, exp val = 0.834, rank #4
- **After:** 6/6 evidence (unchanged), still exp val = 0.834, rank #4
- **Impact:** Remains Priority #1

**Compound Characterization:**
- **Current:** Cell-based IC50 data only
- **After:** Target IC50s + cell IC50s + CRISPR hits + docking
- **Impact:** Complete compound profile

**Pathway Analysis:**
- **Current:** DepMap-based only
- **After:** DepMap + CRISPR synthetic lethality
- **Impact:** Validated pathway dependencies

**Combination Therapy:**
- **Current:** Computational predictions
- **After:** CRISPR-validated synthetic lethal partners
- **Impact:** Evidence-based combinations

---

## ‚è±Ô∏è TIME ESTIMATES

**Phase 1 (Quick Wins):** 30 minutes  
**Phase 2 (High Value):** 3 hours  
**Phase 3 (AML Critical):** 4 hours  

**TOTAL:** ~7.5 hours of focused work

**Buffer:** Add 2 hours for debugging = **9.5 hours total**

**Realistic Timeline:**
- Start: Now
- Complete Phase 1: 30 min from now
- Complete Phase 2: 4 hours from now
- Complete Phase 3: 8-10 hours from now
- **Ready for PROMPT 5: Tonight or tomorrow morning**

---

## üö¶ GO/NO-GO DECISIONS

### Must Complete Before PROMPT 5:
‚úÖ **MUST:** 814L IC50 integration (15 min) - Target validation  
‚úÖ **MUST:** AML DEG integration (4 hours) - Critical for AML case  
‚ö†Ô∏è **SHOULD:** CRISPR screen integration (2 hours) - High value  
‚ö™ **NICE:** Docking integration (1 hour) - Supporting evidence  

### If Time-Constrained:
**Minimum Viable:** 814L IC50 + AML DEGs = 4.5 hours  
**Recommended:** Above + CRISPR screens = 6.5 hours  
**Complete:** Above + Docking = 7.5 hours  

---

## ‚úÖ INTEGRATION CHECKLIST

### Before Starting PROMPT 5:

**Required:**
- [ ] 814L target IC50s integrated
- [ ] AML DEG data parsed and integrated
- [ ] AML experimental validation score updated
- [ ] Final rankings recalculated with AML DEGs
- [ ] All data validated

**Strongly Recommended:**
- [ ] CRISPR screen data integrated
- [ ] Synthetic lethal genes identified
- [ ] Pathway analysis updated
- [ ] Combination recommendations enhanced

**Optional:**
- [ ] Docking binding energies extracted
- [ ] Structural validation documented
- [ ] SMILES structures referenced

---

## üéØ BOTTOM LINE

**Current State:** 10/30 files integrated (33%)  
**Target State:** 26/30 files integrated (87%) - Skip 4 QC files  
**Gap:** 16 files need integration  
**Critical Files:** 10 (814L, 6 AML DEGs, 3 CRISPR)  
**Time Needed:** 7-10 hours focused work  

**Recommendation:**  
**START INTEGRATION NOW. DO NOT PROCEED TO PROMPT 5 UNTIL:**
1. ‚úÖ 814L IC50 integrated (15 min)
2. ‚úÖ AML DEGs integrated (4 hours)  
3. ‚úÖ CRISPR screens integrated (2 hours)

**This will give us a truly complete and defensible analysis.**

---

**Ready to begin? Let's start with Phase 1 (30 minutes).**
